Integrated Approach to Biomarkers
Biomarkers Inform the Drug Development Process for Large and Small Molecule Drugs
Altasciences can extract meaningful data from measuring various intracellular, membrane-bound, and secreted circulating biomarkers to inform the development process.
We will help guide you towards a robust and fit-for-purpose biomarker solution involving veteran scientists, toxicologists and clinical pharmacologists to develop a comprehensive preclinical to clinical plan to maximize the translation of results from one phase to the next.
Expertise working with:
|
Experience with the following studies:
|
You may also be interested in the following:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.